跳至主要内容
临床试验/ISRCTN45049889
ISRCTN45049889已完成未知

Irregular vaginal bleeding with etonorgestrel contraceptive implant: a pilot randomised controlled trial of prophylactic down regulation with a gonadotrophin releasing hormone analogue prior to implant insertion

niversity Hospitals of Leicester NHS Trust (UK)0 个研究点目标入组 90 人开始时间: 2008年8月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Women aged 20 - 40 years
  • 2. Requesting Implanon® for contraception after appropriate counselling and consent
  • 3. Willing to follow study protocol
  • 4. Informed consent to participate in study

排除标准

  • 1. Contraindications to Implanon®:
  • 1.1. Pregnancy
  • 1.2. Undiagnosed vaginal bleeding
  • 1.3. Severe arterial disease
  • 1.4. Liver adenoma
  • 1.5. Porphyria
  • 1.6. Active gestational trophoblastic disease
  • 1.7. Sex-steroid dependent cancer
  • 1.8. Enzyme inducing medication
  • 2. Contraindications to GnRHa:
  • 2.1. Pregnancy
  • 2.2. Undiagnosed vaginal bleeding
  • 2.3. Breastfeeding
  • 2.4. Metabolic bone disease
  • 3. Unwilling to keep a regular menstrual diary
  • 4. Unwilling to follow study protocol
  • 5. Unable to understand patient information leaflet
  • 6. Current involvement in other research projects
  • 7. Within six weeks of termination of pregnancy

研究者

发起方
niversity Hospitals of Leicester NHS Trust (UK)

相似试验

A study to determine whether a single hormone... | 临床试验